Top compounds associated with response to RP11-322N21.2


Feature Type Standardized
Nominal ANOVA
mRNA foretinib CTRPv2 pan-cancer AAC -0.059 0.09
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.09
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC -0.23 0.09
mRNA CD-437 CTRPv2 pan-cancer AAC -0.053 0.09
mRNA piperlongumine CTRPv2 pan-cancer AAC -0.052 0.09
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.1
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.051 0.1
mRNA ETP-46464 CTRPv2 pan-cancer AAC -0.067 0.1
mRNA IU1 CTRPv2 pan-cancer AAC -0.061 0.1
mRNA avicin D CTRPv2 pan-cancer AAC -0.085 0.1
Download CSV